REVB CEO reports mandatory tax-related share sale
Revelation Biosciences, Inc. CEO James Rolke reported a mandatory tax-related share disposition.
Rhea-AI Filing Summary
Revelation Biosciences, Inc. CEO James Rolke reported a mandatory tax-related share disposition. On the vesting of restricted stock awards, the issuer sold 10,115 shares of common stock on his behalf solely to cover required tax withholding obligations.
The weighted average sale price was $1.13 per share, with individual trades between $1.12 and $1.14. After this tax-withholding transaction, Rolke directly holds 214,738 shares of common stock. The footnotes state he did not exercise investment discretion over these sales.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise Price or Tax Liability | Common Stock | 10,115 | $1.13 | $11K |
Footnotes (2)
- F1. Represents shares sold by the issuer on behalf of the reporting person solely to satisfy required tax withholding obligations arising upon the vesting of restricted stock awards. The transaction was mandatory and the reporting person did not exercise investment discretion with respect to the sale.
- F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.12 to $1.14, inclusive. The reporting person undertakes to provide to Revelation Biosciences, Inc. (REVB), any security holder of REVB, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Key Figures
Key Terms
tax withholding financial
restricted stock awards financial
weighted average price financial
Form 4 regulatory
non-derivative financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did REVB CEO James Rolke report on this Form 4?
What does the weighted average price mean in the REVB CEO Form 4 filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.